Cargando…

Aberrant Methylation of CDH13 is a Potential Biomarker for Predicting the Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer

BACKGROUND: CDH13 is a novel tumor suppressor gene often inactivated by aberrant promoter methylation in human cancers. Previous studies have shown that CDH13 methylation correlated with advanced disease and poor prognosis in non-muscle invasive bladder cancer (NMIBC). The aim of the current study w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Ying-Li, Xie, Pei-Gen, Ma, Jian-Guo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2014
Materias:	Molecular Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162450/ https://www.ncbi.nlm.nih.gov/pubmed/25196672 http://dx.doi.org/10.12659/MSM.892130

Ejemplares similares

Aberrant methylation of CDH13 can be a diagnostic biomarker for lung adenocarcinoma
por: Pu, Weilin, et al.
Publicado: (2016)

CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer
por: Hibi, K, et al.
Publicado: (2004)

Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis
por: Chen, Feng, et al.
Publicado: (2016)

Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer
por: Pimson, Charinya, et al.
Publicado: (2016)

miR-150 Modulates Cisplatin Chemosensitivity and Invasiveness of Muscle-Invasive Bladder Cancer Cells via Targeting PDCD4 In Vitro
por: Lei, Ye, et al.
Publicado: (2014)

Clinical Relevance of CDH1 and CDH13 DNA-Methylation in Serum of Cervical Cancer Patients
por: Abudukadeer, Abida, et al.
Publicado: (2012)

Conflicting Roles of ZFP36L1 in Regulating the Progression of Muscle Invasive Bladder Cancer
por: Yuan, Simin, et al.
Publicado: (2022)

Data on the function of CDH17 in pancreatic cancer growth
por: Yuan, Hao, et al.
Publicado: (2019)

Up-Regulation of miR-9 Target CBX7 to Regulate Invasion Ability of Bladder Transitional Cell Carcinoma
por: Xie, Dalong, et al.
Publicado: (2015)

Methylation pattern of CDH13 gene in digestive tract cancers
por: Hibi, K, et al.
Publicado: (2004)

Aberrant Nuclear Export of circNCOR1 Underlies SMAD7-Mediated Lymph Node Metastasis of Bladder Cancer
por: An, Mingjie, et al.
Publicado: (2022)

cdh23 affects congenital hearing loss through regulating purine metabolism
por: Yang, Shu, et al.
Publicado: (2023)

Aberrant methylation of SPARC in human lung cancers
por: Suzuki, M, et al.
Publicado: (2005)

Aberrant Methylation of Aging-Related Genes in Asthma
por: Yang, Yu, et al.
Publicado: (2021)

Damaged DNA-binding Protein 1 (DDB1) Interacts with Cdh1 and Modulates the Function of APC/C(Cdh1)
por: Lv, Xiao-Bin, et al.
Publicado: (2010)

Niacin Suppresses Progression of Atherosclerosis by Inhibiting Vascular Inflammation and Apoptosis of Vascular Smooth Muscle Cells
por: Su, Gang, et al.
Publicado: (2015)

A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients
por: Huang, Hai, et al.
Publicado: (2023)

Chromosomal aberrations and prognostic analysis of secondary acute myeloid leukemia—a retrospective study
por: Song, Mingzhu, et al.
Publicado: (2023)

An integrative characterization of recurrent molecular aberrations in glioblastoma genomes
por: Sintupisut, Nardnisa, et al.
Publicado: (2013)

Identification and Immunocorrelation of Prognosis-Related Genes Associated With Development of Muscle-Invasive Bladder Cancer
por: Li, Jingxian, et al.
Publicado: (2021)

Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium
por: Nomura, Tomoe, et al.
Publicado: (2013)

Identification of prognostic biomarkers associated with stromal cell infiltration in muscle‐invasive bladder cancer by bioinformatics analyses
por: Li, Pan, et al.
Publicado: (2020)

HumanMethylation450K Array–Identified Biomarkers Predict Tumour Recurrence/Progression at Initial Diagnosis of High-risk Non-muscle Invasive Bladder Cancer
por: Kitchen, Mark O, et al.
Publicado: (2018)

High-throughput sequencing approach for the identification of lncRNA biomarkers in hepatocellular carcinoma and revealing the effect of ZFAS1/miR-150-5p on hepatocellular carcinoma progression
por: Zhu, Peng, et al.
Publicado: (2023)

Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis
por: Li, Jia Jie, et al.
Publicado: (2022)

Identification of Aberrant Chromosomal Regions in Human Breast Cancer Using Gene Expression Data and Related Gene Information
por: Wang, Hong-Jiu, et al.
Publicado: (2015)

CDH13 promoter SNPs with pleiotropic effect on cardiometabolic parameters represent methylation QTLs
por: Putku, Margus, et al.
Publicado: (2014)

Interactive association between dietary fat and sex on CDH13 cg02263260 methylation
por: Shiu, Bei-Hao, et al.
Publicado: (2021)

Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro
por: Zhuang, Chengle, et al.
Publicado: (2021)

Influence of IL17A polymorphisms on the aberrant methylation of DAPK and CDH1 in non-cancerous gastric mucosa
por: Arisawa, Tomiyasu, et al.
Publicado: (2012)

Rapid Cdc13 turnover and telomere length homeostasis are controlled by Cdk1-mediated phosphorylation of Cdc13
por: Tseng, Shun-Fu, et al.
Publicado: (2009)

The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer
por: Vrieling, Alina
Publicado: (2018)

Knockout of Drosophila RNase Z(L) impairs mitochondrial transcript processing, respiration and cell cycle progression
por: Xie, Xie, et al.
Publicado: (2015)

Metabolomics analysis reveals distinct profiles of nonmuscle‐invasive and muscle‐invasive bladder cancer
por: Sahu, Divya, et al.
Publicado: (2017)

Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells
por: Gao, Xin, et al.
Publicado: (2020)

Inhibition of T24 and RT4 Human Bladder Cancer Cell Lines by Heterocyclic Molecules
por: Zhao, Zhi-Feng, et al.
Publicado: (2017)

A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis
por: Yang, Jingyu, et al.
Publicado: (2016)

Urinary biomarker for the detection of recurrence following non-muscle invasive bladder cancer: are we there yet?
por: Tan, Wei Shen, et al.
Publicado: (2018)

HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder
por: Latif, Z, et al.
Publicado: (2003)

Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
por: Menyhárt, Otília, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2pheo9j64m3o6ij6ad8afik4qt